Literature DB >> 3465719

Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines.

A Rizzino, E Ruff.   

Abstract

Recent studies have determined that fibroblast growth factor (FGF) potentiates the soft agar growth responses of NRK-49F cells to several combinations of transforming growth factors (TGFs). In the current study, two other non-transformed cell lines, NR-6 and AKR-2B, which do not spontaneously form colonies in soft agar, were examined for their soft agar growth responses to FGF. Both the acidic form and basic form of FGF were found to induce the soft agar growth of these cells. In the case of NR-6 cells, the effects of TGF-beta were also examined. TFG-beta potentiated the soft agar growth response of NR-6 cells to FGF, but on its own did not induce soft agar growth. Attempts to identify other factors capable of modulating the response of these cells to FGF, led to the finding that both 12-O-tetra-decanoylphorbol-13-acetate and retinoic acid suppress FGF-induced soft agar growth of NR-6 cells and AKR-2B cells. The finding that FGF induces the soft agar growth of both non-transformed cell lines, together with the findings of others that both forms of FGF are angiogenic, lends further support to the suggestion that FGF plays a significant role in the in vivo growth of some, and possibly many, tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465719     DOI: 10.1007/BF02621092

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  35 in total

1.  Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.

Authors:  R M Pruss; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

Review 2.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

3.  Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts.

Authors:  B B Olwin; S D Hauschka
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

4.  Action of retinoids on the anchorage-independent growth of normal rat kidney fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate or sarcoma growth factor.

Authors:  A M Jetten
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

5.  Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells.

Authors:  A M Jetten; R H Goldfarb
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

6.  Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors.

Authors:  J S Huang; S S Huang; T F Deuel
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

7.  Cellular transformation by coordinated action of three peptide growth factors from human platelets.

Authors:  R K Assoian; G R Grotendorst; D M Miller; M B Sporn
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

8.  Behavior of transforming growth factors in serum-free media: an improved assay for transforming growth factors.

Authors:  A Rizzino
Journal:  In Vitro       Date:  1984-10

9.  Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.

Authors:  A Rizzino; E Ruff; H Rizzino
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

10.  Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities.

Authors:  G Gimenez-Gallego; G Conn; V B Hatcher; K A Thomas
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

View more
  11 in total

1.  TGF-beta does not appear to mediate all effects of 12-O-tetradecanoylphorbol-13-acetate on the anchorage-independent growth of murine epithelial JB6 cells.

Authors:  P J Wilder; A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650.

Authors:  B M Carey; M Dooley; R Weedle; M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

3.  Characterization of fibroblast growth factor activity secreted by embryonal carcinoma cells.

Authors:  K Miller; A Rizzino
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-10       Impact factor: 2.416

4.  Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds.

Authors:  Alexander Moncion; Melissa Lin; Eric G O'Neill; Renny T Franceschi; Oliver D Kripfgans; Andrew J Putnam; Mario L Fabiilli
Journal:  Biomaterials       Date:  2017-06-09       Impact factor: 12.479

5.  Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.

Authors:  K Miller; P J Wilder; A Rizzino
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Polyomavirus middle tumor antigen increases responsiveness to growth factors.

Authors:  L Raptis
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Effect of retinoids on growth factor-induced anchorage independent growth of human fibroblasts.

Authors:  H J Palmer; V M Maher; J J McCormick
Journal:  In Vitro Cell Dev Biol       Date:  1989-11

8.  Transformed phenotype conferred to NIH/3T3 cells by ectopic expression of heparin-binding growth factor 1/acidic fibroblast growth factor.

Authors:  P Bunnag; K S Waddell; M L Varban; I M Chiu
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

9.  Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells.

Authors:  J Tiesman; A Meyer; R N Hines; A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

10.  Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells.

Authors:  M Jaye; R M Lyall; R Mudd; J Schlessinger; N Sarver
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.